Pancreatic Cancer Research

ResearcherMarche Polytechnic UniversityActive in the last 2 years

Rossana Berardi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9529-2960; OpenAlex author ID A5019053015. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
55
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 13

  1. TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreat… Co-author DOI 10.1200/jco-25-00872↗
  2. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine pl… Co-author DOI 10.1016/j.dld.2022.11.012↗
  3. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Last author DOI 10.1200/jco.22.01134↗
  4. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomi… First author DOI 10.1016/j.ejca.2021.02.023↗
  5. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer. Last author DOI 10.21037/atm-20-3499↗
  6. Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.657965↗
  7. Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients. Last author DOI 10.3390/curroncol28050303↗
  8. The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Co-author DOI 10.1177/1179554920936605↗
  9. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival. Co-author DOI 10.3389/fonc.2019.00874↗
  10. Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: a new strategy to improve immunotherapy efficacy? Co-author DOI 10.21037/jtd.2017.06.60↗
  11. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib. Co-author DOI 10.18632/oncotarget.5197↗
  12. Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study. First author DOI 10.1016/j.dld.2013.09.020↗
  13. Treatment trends in metastatic pancreatic cancer patients: Is it time to change? Co-author DOI 10.1016/j.dld.2010.09.010↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessandro Bittoni · 6 shared papers, 2015–2021 · strength 0.59
  2. Mario Scartozzi · 2 shared papers, 2015–2023 · strength 0.19
  3. Roberto Labianca · 3 shared papers, 2014–2021 · strength 0.17
  4. Stefania Mosconi · 3 shared papers, 2014–2021 · strength 0.17
  5. Stefano Cascinu · 3 shared papers, 2014–2021 · strength 0.17
  6. Jean‐Luc Van Laethem · 1 shared paper, 2025 · strength 0.16
  7. Mariano Ponz‐Sarvisé · 1 shared paper, 2025 · strength 0.16
  8. Rocio García‐Carbonero · 1 shared paper, 2025 · strength 0.16
  9. Christophe Tournigand · 1 shared paper, 2025 · strength 0.16
  10. Fabienne Portales · 1 shared paper, 2025 · strength 0.16
  11. Isabelle Trouilloud · 1 shared paper, 2025 · strength 0.16
  12. Roberto Pazo-Cid · 1 shared paper, 2025 · strength 0.16
  13. Manuel M. Hidalgo · 1 shared paper, 2025 · strength 0.16
  14. Marcus Smith Noel · 1 shared paper, 2025 · strength 0.16
  15. Jaime Feliú · 1 shared paper, 2025 · strength 0.16
  16. Christos K Fountzilas · 1 shared paper, 2025 · strength 0.16
  17. Bruno Bockorny · 1 shared paper, 2025 · strength 0.16
  18. Pascal R. Hammel · 1 shared paper, 2025 · strength 0.16
  19. Jean‐Baptiste Bachet · 1 shared paper, 2025 · strength 0.16
  20. Harpreet Singh Wasan · 1 shared paper, 2025 · strength 0.16
  21. David Tougeron · 1 shared paper, 2025 · strength 0.16
  22. Eric Van Cutsem · 1 shared paper, 2025 · strength 0.16
  23. Teresa Mercade Macarulla · 1 shared paper, 2025 · strength 0.16
  24. Olivier Bouché · 1 shared paper, 2025 · strength 0.16
  25. Massimo Falconi · 2 shared papers, 2011–2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.